Generic drugs don't appear immediately after patent expiration. Legal delays, patent thickets, and regulatory hurdles can push market launch out by years - costing patients billions. Here's how the system really works.
Read More
The Hatch-Waxman Act created the modern system for generic drug approval in the U.S., balancing innovation incentives with affordable access. It saved trillions but faces growing abuse.
Read More